| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.01B | +28.6% |
| Cost of Revenue | $3.24B | +28.9% |
| Gross Profit | $5.77B | +28.4% |
| R&D Expense | $1.24B | +24.1% |
| SG&A Expense | $141.9M | +15.6% |
| Operating Income | $3.86B | +31.0% |
| Pre-tax Income | $4.25B | +30.2% |
| Income Tax | $738.3M | +78.8% |
| Net Income | $3.51B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.96B | -28.9% |
| Accounts Receivable | $1.89B | +65.4% |
| Inventory | $2.25B | +22.5% |
| Current Assets | $16.39B | +37.6% |
| Total Assets | $19.45B | +38.5% |
| Current Liabilities | $5.38B | +96.8% |
| Total Liabilities | $7.08B | +74.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.37B | +17.9% |
| Investing Cash Flow | -$3.58B | -45.5% |
| Financing Cash Flow | -$1.60B | -278.3% |
| +23.1% |
| EPS (Basic) | $2.79 | +22.9% |
| EPS (Diluted) | $2.75 | +23.3% |
| Stockholders' Equity |
| $12.37B |
| +23.8% |